Notable Facts
→CFO of publicly traded biotech company Travere Therapeutics since August 2022
→CFA charter holder with 15+ years experience in investor relations
→Previously SVP of Investor Relations & Corporate Communications at Travere since 2014
→Holds finance degree from Xavier University Williams College of Business
→Based in New York with 500+ LinkedIn connections
→Worked at Elan Corporation and Phase Forward before Travere
→Active in investor conferences and analyst meetings